The idea of catching Novo Nordisk ADR (NVO) Stock might be a good one
BMO Capital Markets raised the price target for the Novo Nordisk ADR (NYSE:NVO) stock to “an Outperform”. The rating was released on April 12, 2024, according to finviz. The stock was initiated by Cantor Fitzgerald, who disclosed in a research note on December 01, 2023, to Overweight and set the price objective to $120. In […]
